Royalty Pharma names Greg Raskin SVP, head of academic initiatives
Reuters2026/08/03 12:15- Royalty Pharma named Greg Raskin senior vice president, head of academic initiatives, effective August 2026.
- He will lead outreach with academic and non-profit institutions, overseeing the Royalty Pharma Translational Prize.
- Raskin previously served as senior vice president, technology development at Memorial Sloan Kettering Cancer Center, leading tech transfer and startup formation.
- Earlier roles include vice president at AllianceBernstein’s venture fund, biotech analyst at Baker Brothers Investments, consultant at McKinsey.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The higher the yen rises, the more retail investors short! 3.61 trillion yen short bets defy the trend, triggering a short squeeze warning
Even though the yen has reached its highest level in months, Japanese retail investors continue to bet that its sharp rebound will come to an end, and are consistently increasing their short positions.
EUR/USD Price Forecast: Bullish bias remains above 1.1600 ahead of ECB and US inflation
Abraxas Capital hedges $353M ETH short with $32M buy – Here’s why
Pons propels Robinhood Chain fees to record $6 million in daily fees as DEX volume doubles
Crypto prices
More
